Podcasts · Lung Cancer Considered

IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy

· 46 min

Episode IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy

0:00 45:40

This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a discussion of the formulation and its place in the management of patients with lung cancer.

Guests:

Cheryl Ho, MD, FRCPC Thoracic Oncologist, BC Cancer Clinical Associate Professor and Fellowship Program Director University of British Columbia

Maria Velez Velez, MD, MS Clinical Instructor, Division of Hematology/Oncology David Geffen School of Medicine at UCLA

The episode on the publisher’s site

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.